Present status of firm unknown. Thyreos Corporation had been a drug development company in receipt of an NIH Phase II in 2002, The firm's President and Founder(aged 85) died during the conduct of that Phase II. The late Dr. Bardin - a giant in the field of endocrinology who contributed substantially to the fieds of reproductive physiology, the development of unique methods of contraception and the clinical care of patients with disorders of reproduction -- had held appointments as Professor of Medicine, Chief of the Division of Endocrinology, The Milton S. Hershey Medical Center of Pennsylvania State University, and Senior Investigator, Endocrinology Branch, National Cancer Institute. He directed basic and clinical research leading to over 500 publications and patents. and served on committees and boards for the National Institute of Health, World Health Organization, The Ford Foundation, and various scientific societies. With a BA from Rice University, MS and MD degrees from Baylor University and honorary degrees from the University of Caen, the University of Paris, and the University of Helsinki.
